Notice on Convening the 3rd Extraordinary General Meeting in 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 3rd Extraordinary General Meeting in 2026
Filed with SSE · · 6 pages · Chinese
Release
Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix
Earlier from Shaanxi Kanghui Pharmaceutical
- Announcement on Release of Pledge and Re-pledge of Some Shares Held by Shareholders with Over 5% Shares
- Announcement on Resolutions of the 11th Meeting of the 6th Board of Directors
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Progress in Providing Supplemental Guarantee for Holding Subsidiary
Later from Shaanxi Kanghui Pharmaceutical
- Announcement on Interim Administrator of Pre-reorganization Case of Holding Subsidiary Shaanxi Youbang Recruiting Interested Investors
- Self-Inspection Report on the Trading of Company's Stock by Information Insiders in 2026 Restricted Stock Incentive Plan
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026
- Announcement on Progress in Outward Investment in Establishing Holding Subsidiaries
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
Follow Shaanxi Kanghui Pharmaceutical into a list and get an email when it puts out news.
Follow Shaanxi Kanghui Pharmaceutical